Physician Use of Non-English Language Skills in Cancer Care

Breast Cancer Clinical Trial

Official title:

Physician Use of Non-English Language Skills in Cancer Care

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02726360
• Other study ID #: 15-316
• Status: Completed
• Start date: December 14, 2015
• Est. completion date: August 21, 2023

Study information

• Verified date: August 2023
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to test a method for analyzing interactions between patients and doctors, the Roter Interaction Analysis System (RIAS). The RIAS measures the quality of communication between patients and their cancer doctors.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 71
• Est. completion date: August 21, 2023
• Est. primary completion date: August 21, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years to 80 Years

Eligibility

Inclusion Criteria:

• is a English or Spanish-speaking patient

• between the ages of 21-80 years old

• has a new diagnosis of any type of cancer (diagnosed within the past 4 months), or has a recurrence of either breast, colon or lung cancer (recurrence diagnosed within the past 4 months)

• scheduled to have surgery or begin chemotherapy and/or radiation therapy within the next 2 months

Oncology clinician Inclusion:

• provides care to LEP patients

• has MD, DO, RN, NP or PA degree

• is between the ages of 21-80

Exclusion Criteria:

• is unable to provide informed consent in either English or Spanish

Related Conditions & MeSH terms

• Breast Cancer
• Colon Cancer
• Colonic Neoplasms
• Lung Cancer

Intervention

Behavioral:
• survey
The ILR Scale, a non-English language proficiency self-assessment.
• Audio record
Audio record the initial visits between patients and their treating physician

Locations

Country	Name	City	State
United States	Lincoln Medical Center	Bronx	New York
United States	Queens Cancer Center of Queens Hospital	Jamaica	New York
United States	Memorial Sloan Kettering Cancer Center	New York	New York
United States	Ralph Lauren Center for Cancer Care and Prevention	New York	New York
United States	Elmhurst Hospital Center	Queens	New York

Sponsors (5)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center	Edward-Elmhurst Health System, Johns Hopkins University, Lincoln Medical and Mental Health Center, Queens Cancer Center of Queens Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	study-specific coding structure	using the RIAS in cancer care across English and Spanish languages will be assessed by evaluating whether this existing, validated coding system 'works' across a language barrier.	2 years

External Links

•   Memorial Sloan Kettering Cancer Center